| Edgewood Rehab & Living Ctr | |
| 221 Fairbanks Rd, Farmington, Maine 04938 | |
| (207) 778-3386 | |
| Name | Edgewood Rehab & Living Ctr |
|---|---|
| Location | 221 Fairbanks Rd, Farmington, Maine |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 33 |
| Occupancy Rate | 74.24% |
| Medicare ID (CCN) | 205131 |
| Legal Business Name | North Country Associates, Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1043370273 |
| Organization Name | NORTH COUNTRY ASSOCIATES, INC |
| Doing Business As | EDGEWOOD LIVING CENTER |
| Address | 221 Fairbanks Rd, Farmington, ME 04938 |
| Phone Number | 207-778-3386 |
News Archive
Edie Littlefield Sundby may not have thought she'd ignite a national debate when the stage-4 cancer survivor asked us to publish her Monday op-ed on losing her oncologist due to the Affordable Care Act. But she certainly has, and it's important to understand why. Mrs. Sundby and millions like her must be denied their medical choices if ObamaCare is going to work as its liberal planners intend (11/6).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
Halfpenny Technologies, Inc., a leading health information exchange (HIE) company that enables interoperability between physician electronic medical record systems (EMRs) and hospitals, laboratories and other ancillary service providers, today announced that American Pathology Partners, a nationwide, private diagnostic testing services provider based in Nashville, Tenn., will deploy the company's Integration Technology Framework (ITF) platform.
The most comprehensive analysis yet of the genetic imbalances at the heart of childhood brain tumors known as high-grade gliomas (HGGs) identified a cancer gene that is unusually active in some tumors and is now the focus of a St. Jude Children's Research Hospital clinical trial.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Edie Littlefield Sundby may not have thought she'd ignite a national debate when the stage-4 cancer survivor asked us to publish her Monday op-ed on losing her oncologist due to the Affordable Care Act. But she certainly has, and it's important to understand why. Mrs. Sundby and millions like her must be denied their medical choices if ObamaCare is going to work as its liberal planners intend (11/6).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
Halfpenny Technologies, Inc., a leading health information exchange (HIE) company that enables interoperability between physician electronic medical record systems (EMRs) and hospitals, laboratories and other ancillary service providers, today announced that American Pathology Partners, a nationwide, private diagnostic testing services provider based in Nashville, Tenn., will deploy the company's Integration Technology Framework (ITF) platform.
The most comprehensive analysis yet of the genetic imbalances at the heart of childhood brain tumors known as high-grade gliomas (HGGs) identified a cancer gene that is unusually active in some tumors and is now the focus of a St. Jude Children's Research Hospital clinical trial.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 9.59 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.85 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 25.71 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.66 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.41 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 22.37 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.16 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.89 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.92 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.43 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.87 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 89.17 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.11 | 82.93 |
News Archive
Edie Littlefield Sundby may not have thought she'd ignite a national debate when the stage-4 cancer survivor asked us to publish her Monday op-ed on losing her oncologist due to the Affordable Care Act. But she certainly has, and it's important to understand why. Mrs. Sundby and millions like her must be denied their medical choices if ObamaCare is going to work as its liberal planners intend (11/6).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
Halfpenny Technologies, Inc., a leading health information exchange (HIE) company that enables interoperability between physician electronic medical record systems (EMRs) and hospitals, laboratories and other ancillary service providers, today announced that American Pathology Partners, a nationwide, private diagnostic testing services provider based in Nashville, Tenn., will deploy the company's Integration Technology Framework (ITF) platform.
The most comprehensive analysis yet of the genetic imbalances at the heart of childhood brain tumors known as high-grade gliomas (HGGs) identified a cancer gene that is unusually active in some tumors and is now the focus of a St. Jude Children's Research Hospital clinical trial.
› Verified 3 days ago